Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 26,386 shares at $50.03 ($1.3M) on 2021-01-14, disclosed to the SEC on 2021-01-14.
Open-market sale of $1.3M RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.01 | 4,200 | $210K | 15.9% |
| 2 | $50.03 | 11,093 | $555K | 42.0% |
| 3 | $50.03 | 11,093 | $555K | 42.0% |
| Total | $50.03 avg | 26,386 | $1.3M | 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |